Our research results align with previous studies demonstrating elevated levels of pro-inflammatory cytokines in AD patients’ CSF [9,10,25], with consequent MMP-9 synthesis, while increased TIMP-1 levels could signify a compensatory mechanism aimed to counterbalancing heightened MMP-9 production. This evidence concerns the gene TIMP1 and Alzheimer disease.